Treatment of Malarial Fever by Unani medicine Maleria
- Conditions
- Health Condition 1: B529- Plasmodium malariae malaria without complication
- Registration Number
- CTRI/2020/05/025253
- Lead Sponsor
- Central Council for Research in Unani Medicine CCRUM New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Patients of either sex of age 18-65 years.
2. Presence of axillary temperature >= 37.5°C (99.5 o F) or oral temperature of > 38 o C
(100.4 o F) or history of fever during the past 24 hours.
3. Mono-infection with P. vivax confirmed by either positive blood smear (i.e. no mixed
infection) or RDT (Rapid Diagnostic Test).
1. Any evidence of severe malaria that would require hospitalization for treatment i.e.
including: impaired consciousness, respiratory distress, severe anaemia (Hb <5),multiple seizures, frequent vomiting/ inability to swallow tablets, prostration, jaundice,
hypotension abnormal bleeding or hypoglycaemia. (acc. to WHO definition)
2. Mixed or mono-infection with Plasmodium species other than P. vivax detected by
microscopy.
3. Patients associated with other known conditions requiring long term treatment like TB,
AIDS, diabetes, hypertension etc.
4. Reported allergy to any antimalarial drugs, including sulfa and artemisinin drugs.
5. Patients with Glucose-6-phosphate dehydrogenase deficiency
6. Pregnant and lactating females.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in signs and symptoms of ḤummÄ? AjÄ?miyya (Malarial Fever)Timepoint: 2 weeks
- Secondary Outcome Measures
Name Time Method Haematological and biochemical assessment for safety assessmentTimepoint: Investigations will be done at baseline and end of treatment